Molecular mechanisms of immunosuppression

Area of Science:

• Immunology
• Pharmacology
• Molecular Biology

Background:

• Cyclosporin A (CsA) is an immunosuppressive drug used for autoimmune disorders.
• The precise molecular mechanism of CsA action remains largely unknown despite its widespread use.

Purpose of the Study:

• To elucidate the molecular mechanism of CsA in T cell activation.
• To differentiate the roles of CsA binding and enzymatic activity in immunosuppression.

Main Methods:

• Compared CsA with cyclophilin-binding cyclosporin analogues (CBCAs) lacking immunosuppressive properties.
• Investigated the necessity of CsA-cyclophilin binding and cyclophilin isomerase activity for immunosuppression.

Main Results:

• CsA binding to cyclophilin is required but insufficient for immunosuppression.
• Inhibition of cyclophilin's peptidyl-prolyl cis-trans isomerase activity is not essential for CsA's effects.
• A distinct 'effector' domain structure on CsA, separate from the immunophilin 'binding' domain, determines biological activity.

Conclusions:

• Understanding CsA's structure-activity relationship is crucial for identifying its mechanism of action and side effects.
• The effector domain, not the binding domain, is key to CsA's immunosuppressive function.